Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
The BET inhibitor/degrader ARV-825 prolongs the growth arrest response to Fulvestrant + Palbociclib and suppresses proliferative recovery in ER-positive breast cancer.
Journal: Frontiers in oncology
Published: June 10, 2022
A Fenofibrate Diet Prevents Paclitaxel-Induced Peripheral Neuropathy in Mice.
Journal: Cancers
Published: December 02, 2020
N-acylethanolamine-hydrolysing acid amidase: A new potential target to treat paclitaxel-induced neuropathy.
Journal: European journal of pain (London, England)
Published: October 05, 2020
Targeting Peroxisome Proliferator-Activated Receptor-α (PPAR- α) to reduce paclitaxel-induced peripheral neuropathy.
Journal: Brain, behavior, and immunity
Published: September 22, 2020
Showing 1-4 of 4
Last Updated: 09/26/2026